Terumo's (TRUMY.PK)
green-and-white color scheme is likely pretty familiar to those who
attend medical conferences (particularly those focused on coronary
treatments), but Terumo is likely not a particularly well-known name to
most American investors.
Not only does Terumo have a strong and
diversified medical device business in Japan, but Terumo's share outside
of Japan suggests bigger things could be in store. These shares are not
particularly easy to own (the ADR is quite illiquid) and the valuation
doesn't suggest that investors need to be in any hurry to figure out how
to work around that, but the significantly above-average growth
potential here makes Terumo very much worth watching.
Please continue here:
Fortune Could Favor A Bolder Terumo
No comments:
Post a Comment